Filings

1 document · 2 matches

1. ACRV Acrivon Therapeutics, Inc. 10-K 2026-03-19

   Item 1A. Risk Factors.

   material weaknesses in our internal control over financial reporting, which were remediated; however, our remediation efforts may not enable us to avoid
   2 matches in this document Show context Copy citation